By contrast, IGF2BP2, whose over-expression correlates with worse overall survival in AML patients [39], and MEIS1 were H3K79me2 enriched only in MLL-r cells, although they were down-regulated by Pinometostat in all AML cells. The gene discussed is KMT2A; the disease is acute myeloid leukemia.